Inside the research

STERIS plc

STE Research profile · latest available data

Price overview

$208.93

▲ +0.16 (+0.1%)

52w hi$266.36
52w lo$198.79
Vol447.10K
As of25 Sep 2026

The Verdict

Hold

Our score -0.07

Short-0.32
Medium+0.03
Long+0.25

computed 2026-09-27

Key fundamentals

STERIS plc

Healthcare · Medical Devices

Market cap$20.37B
Enterprise value$21.95B
Trailing P/E25.51x
Forward P/E17.06x
EV / EBITDA13.38x
P / S (ttm)3.37x
Profit margin13.3%
Return on equity11.4%
Revenue growth+7.3%
Earnings growth+14.0%
Debt / equity28.31

Layer Breakdown

LayerRawContribution
Fundamental+0.27
Sector+0.08
Technical-0.21
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.

United States · www.steris.com

Risk Metrics

Beta vs SPX0.51
Corr SPX0.34
Annual vol24.1%
Annual ret-3.4%
Sharpe-0.14
Max DD-25.8%

Window: 504 trading days (504 obs)

Analyst Coverage

Mean PT$279.29
High / Low$300.00 / $231.00
Median$291.00
Analysts7
Strong Buy2
Buy3
Hold2
Sell0
Strong Sell1

Recent rating actions

2025-08-08Morgan Stanley→ Overweight
2025-07-22Keybanc→ Overweight
2025-07-15Morgan Stanley→ Overweight
2025-05-29Jefferies→ Hold
2025-05-19Morgan Stanley→ Equal-Weight
2025-05-16JMP Securities→ Market Outperform

Material Events

DateEvent8-K
2026-08-06Shareholder Voteread
2026-08-05Earnings Release, Restructuring…read
2026-05-11Earnings Release, Exhibitsread
2026-05-07Officer / Director Change, Reg FD Disclosure…read
2026-04-06Officer / Director Changeread
2026-02-04Earnings Release, Exhibitsread
2025-11-05Earnings Release, Exhibitsread
2025-08-06Earnings Release, Officer / Director Change…read
2025-07-03Officer / Director Changeread
2025-05-14Earnings Release, Exhibitsread
2025-03-03Other Material Eventread
2025-02-05Earnings Release, Exhibitsread

Dividends

Yield (TTM)0.30%
$ / share (TTM)$0.63
5y CAGR+2.8%

Annual dividend per share

2021$1.66
2022$1.80
2023$1.98
2024$2.18
2025$1.77
2026$0.63

SEC Filings

DateFormDoc
2026-08-124view
2026-08-124view
2026-08-124view
2026-08-124view
2026-08-124view
2026-08-124view
2026-08-124view
2026-08-124view
2026-08-0710-Qview
2026-08-068-Kview
2026-08-068-K/Aview
2026-08-058-Kview
2026-07-024view
2026-06-164view
2026-06-1611-Kview

The Long Run

FY 2019–2025 · 7 years

LineLatestCAGRTrend
Revenue$4.54B+37.2%
Gross profit$1.98B+9.1%
Operating income$836.12M+12.5%
Net income$107.03M+10.7%
Cash from ops$1.15B+18.1%

Indices

S&P 500

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$208.11$209.69$207.21$208.93447.10K
Sep 24$210.05$211.45$208.57$208.77524.40K
Sep 23$208.41$210.33$207.07$209.98534.00K
Sep 22$208.98$209.12$205.21$208.79624.60K
Sep 21$205.36$207.46$203.32$206.97984.60K

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →